Sima Bhatt

Profile picture
Assistant Professor of Pediatrics, Hematology and Oncology
Hematology and Oncology

phone: (314) 454-6018


  • BS, University of Illinois2006
  • MD, Rush University2010
  • MSCI, Washington University2018


  • Residency, University of Chicago2010 - 2013
  • Fellowship, Washington University2014 - 2017

Licensure and Board Certification

  • 2013 - 2023American Board of Pediatrics/General Pediatrics
  • 2015 - PresMO, State of Missouri
  • 2019 - 2029American Board of Pediatrics/Hematology Oncology


  • Arnold P. Gold Foundation Humanism and Excellence in Teaching Award2013
  • Ash Abstract Award2016
  • David Gilstrap Award2017

Recent Publications view all (7)

Publication Co-Authors

  1. Immune Reconstitution and Infection Patterns Following Early Alemtuzumab and Reduced Intensity Transplantation for Non-Malignant Disorders in Pediatric Patients. BBMT. 2018. PMID:30321596 
  2. Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS. Blood. 2018;131(9):1032-1035. PMCID:PMC5833264  PMID:29358180 
  3. The Role of Toll-Like Receptors in Hematopoietic Malignancies. Front Immunol. 2016;7:390. PMCID:PMC5039188  PMID:27733853 
  4. Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms. Blood Cancer J. 2016;6:e437. PMCID:PMC5141360  PMID:27315114 
  5. A 12-week-old male with a 10-day history of fever. Pediatr Ann. 2014;43(5):e111-5. PMID:24877492 
  6. A single center experience using alemtuzumab, fludarabine, melphalan and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease PBC. 
  7. Engraftment of rare, pathogenic donor hematopoietic clones with mutations in unrelated hematopoietic stem cell transplantation Sci. Transl. Med.. 
Last updated: 09/30/2019
© 2019 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130